SCHEMBL22172198

SCHEMBL22172198

Clc1ccc2c(c1)sc1c3ccccc3ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1B1 Q16678 8/20 0.52
▸ CYP1A1 P04798 7/20 0.52
▸ CYP1A2 P05177 5/20 0.52
▸ CYP2A6 P11509 3/20 0.44
▸ MCL1 Q07820 2/20 0.40
▸ BCL2 P10415 1/20 0.40
▸ BCL2L1 Q07817 1/20 0.40
▸ BAD Q92934 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ TOP1 P11387 1/20 0.39
▸ TOP2A P11388 1/20 0.39
▸ BCKDK O14874 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ HPRT1 P00492 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ AHR P35869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23024877 0.88 CYP1A1 (0.51) CYP1B1CYP1A1CYP1A2CYP2A6KDM4E
SCHEMBL25733726 0.87 CYP1A1 (0.48) CYP1B1CYP1A1CYP1A2CYP2A6MCL1
SCHEMBL22650689 0.86 KDM4E (0.47) CYP1B1CYP1A1CYP1A2CYP2A6KDM4E
SCHEMBL24888400 0.86 KDM4E (0.51) CYP1B1CYP1A1CYP1A2CYP2A6KDM4E
SCHEMBL12070495 0.83 CYP1B1 (0.49) CYP1B1CYP1A1CYP1A2CYP2A6KDM4E
SCHEMBL17356224 0.82 CYP1B1 (0.49) CYP1B1CYP1A1CYP1A2CYP2A6MCL1
SCHEMBL13562189 0.81 KDM4E (0.46) CYP1B1CYP1A1CYP1A2CYP2A6KDM4E
SCHEMBL1294668 0.81 GPR3 (0.54) CYP1B1CYP1A1CYP1A2CYP2A6HPRT1
SCHEMBL29903935 0.81 GPR3 (0.54) CYP1B1CYP1A1CYP1A2CYP2A6HPRT1
SCHEMBL25733722 0.81 KDM4E (0.50) CYP1B1CYP1A1CYP1A2CYP2A6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-08-03 — — US disclosed
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-08-03 — — US disclosed
WO-2023287228-A1 ORGANIC LIGHT EMITTING DEVICE 주식회사 엘지화학 2023-01-19 — — WO disclosed
WO-2022045743-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME 주식회사 엘지화학 2022-03-03 — — WO disclosed
US-20210077458-A1 DIBENZOTHIOPHENE DERIVATIVES AND METHODS OF TREATING CANCER THEREWITH SAINT LOUIS UNIVERSITY (US) 2021-03-18 — — US disclosed
WO-2020138726-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING ORGANIC ELECTRIC ELEMENT 덕산네오룩스 주식회사 2020-07-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210077458-A1 DIBENZOTHIOPHENE DERIVATIVES AND METHODS OF TREATING CANCER THEREWITH BRCA1, TP53, DDX21 CYP1B1 152/4885CYP1A1 469/4885CYP1A2 578/4885
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CRY2, NR1D1 CYP1B1 43/4885CYP1A1 8/4885CYP1A2 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback